X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (244) 244
female (237) 237
index medicus (235) 235
oncology (181) 181
women (171) 171
ovarian cancer (165) 165
mutation (148) 148
surgery (146) 146
adult (143) 143
middle aged (142) 142
cancer (138) 138
breast cancer (132) 132
ovarian-cancer (125) 125
ovariectomy (121) 121
genes, brca1 (114) 114
ovarian neoplasms - genetics (114) 114
risk factors (113) 113
prevention (110) 110
genes, brca2 (106) 106
ovarian neoplasms - prevention & control (100) 100
risk reduction behavior (100) 100
obstetrics & gynecology (97) 97
breast neoplasms - genetics (96) 96
genetic predisposition to disease (93) 93
aged (91) 91
brca1 (90) 90
brca (83) 83
risk reduction (82) 82
genetic aspects (80) 80
health aspects (78) 78
risk-reducing salpingo-oophorectomy (78) 78
prophylactic oophorectomy (69) 69
breast-cancer (68) 68
reducing salpingo-oophorectomy (67) 67
brca2 mutation carriers (65) 65
breast neoplasms - prevention & control (64) 64
breast (61) 61
heterozygote (61) 61
risk-reducing surgery (61) 61
hormone replacement therapy (60) 60
salpingo-oophorectomy (60) 60
brca2 (57) 57
research (57) 57
fallopian tubes (56) 56
brca1 protein - genetics (51) 51
quality-of-life (50) 50
gene mutations (49) 49
fallopian-tube (48) 48
brca2 protein - genetics (47) 47
ovarian neoplasms - surgery (47) 47
diagnosis (46) 46
genetic testing (46) 46
mastectomy (46) 46
salpingectomy (45) 45
risk assessment (43) 43
genetics & heredity (42) 42
mutation carriers (42) 42
risk (41) 41
hysterectomy (39) 39
menopause (39) 39
genetic counseling (38) 38
breast neoplasms - surgery (37) 37
obstetrics and gynecology (37) 37
carriers (36) 36
health risk assessment (36) 36
oophorectomy (36) 36
family-history (35) 35
article (34) 34
follow-up (34) 34
retrospective studies (34) 34
hematology, oncology and palliative medicine (32) 32
oncology, experimental (31) 31
prospective studies (30) 30
genetic screening (29) 29
decision making (28) 28
ovariectomy - methods (28) 28
care and treatment (27) 27
prophylactic mastectomy (27) 27
bilateral prophylactic mastectomy (26) 26
endocrine system diseases (26) 26
fallopian tubes - surgery (26) 26
ovarian neoplasms - pathology (26) 26
brca1 protein (25) 25
hereditary breast (25) 25
medicine & public health (25) 25
reduction (25) 25
womens health (25) 25
genetics (24) 24
ovarian carcinoma (24) 24
abridged index medicus (23) 23
endometrial cancer (23) 23
germline mutations (23) 23
young adult (23) 23
brca mutation (22) 22
cancer research (22) 22
carcinoma (22) 22
germ-line mutation (22) 22
metaanalysis (22) 22
mortality (22) 22
skin and connective tissue diseases (22) 22
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (345) 345
French (8) 8
Polish (4) 4
German (3) 3
Japanese (3) 3
Czech (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gynecologic Oncology, ISSN 0090-8258, 2015, Volume 140, Issue 1, pp. 95 - 100
Journal Article
International Journal of Gynecological Cancer, ISSN 1048-891X, 2017, Volume 27, Issue 4, pp. 847 - 852
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2015, Volume 107, Issue 5, p. 1
Journal Article
European Journal of Cancer, ISSN 0959-8049, 10/2017, Volume 84, pp. 159 - 167
Journal Article
Journal Article
Journal Article
International Journal of Gynecological Cancer, ISSN 1048-891X, 09/2016, Volume 26, Issue 7, pp. 1338 - 1344
Journal Article
JOURNAL OF MEDICAL GENETICS, ISSN 0022-2593, 09/2016, Volume 53, Issue 9, pp. 591 - 599
Background Risk-reducing salpingo-oophorectomy (RRSO) is the most effective intervention to prevent ovarian cancer (OC). It is only available to high-risk... 
BRCA2 MUTATION CARRIERS | cost-effectiveness | risk reducing salpingo-oophorectomy | HORMONE REPLACEMENT THERAPY | Ovarian cancer | risk threshold | BREAST-CANCER | GENETIC SUSCEPTIBILITY | WOMEN | ECONOMIC-EVALUATION | GENETICS & HEREDITY | GERMLINE MUTATIONS | CONFER SUSCEPTIBILITY | QUALITY-OF-LIFE | HEALTH | surgical prevention
Journal Article
Climacteric, ISSN 1369-7137, 07/2019, Volume 22, Issue 4, pp. 352 - 360
Background: Women at high risk to develop ovarian cancer opt for risk-reducing salpingo-oophorectomy (RRSO) to reduce the risk by 80-96%. RRSO leads to a... 
cancer screening | BRCA; menopause | ovarian cancer | risk-reducing salpingo-oophorectomy | breast cancer | guidelines | Hormone replacement therapy | BONE-MINERAL DENSITY | HYSTERECTOMY | OVARIAN-CANCER | OBSTETRICS & GYNECOLOGY | BRCA | menopause | BRCA1 MUTATION CARRIERS | TIBOLONE | HEALTH | POSTMENOPAUSAL WOMEN | PROPHYLACTIC OOPHORECTOMY | MAMMOGRAPHIC BREAST DENSITY
Journal Article
Maturitas, ISSN 0378-5122, 05/2018, Volume 111, pp. 69 - 76
To reduce the risk of ovarian cancer, women with mutations are advised to undergo risk-reducing salpingo-oophorectomy (RRSO) at a premenopausal age.... 
Vasomotor symptoms | Surgical menopause | Risk-reducing salpingo-oophorectomy | Breast cancer | Sexual functioning | Prevention | Ovariectomy | Surgery | Menopause | Fallopian tubes | Sexual disorders | Cancer | Ovarian cancer
Journal Article
European Journal of Surgical Oncology, ISSN 0748-7983, 09/2019
Journal Article
European Journal of Cancer, ISSN 0959-8049, 10/2017, Volume 84, p. 159
Background There has been some doubts raised in earlier studies about the efficacy of hormone replacement therapy (HRT) in reducing endocrine and sexual... 
Therapy | Ovarian carcinoma | Ovariectomy | Menopause | Sexual behavior | Health risks | Risk reduction | Ovarian cancer | Risk assessment | Surgery | Hormone replacement therapy | Mathematical models | Cancer
Journal Article